drugset
drugset / Trial / NCT03787147

Assessing the Efficacy of Virtual Reality Analgesia (VRA) in Adult Patients for Pain Control During Spinal Injections (SI)

NCT03787147 ↗

Phase 2 Withdrawn Albert Einstein College of Medicine
RandomizedParallel-groupDouble-blindSupportive care

Summary

A three-group parallel randomized controlled trial to evaluate the efficacy of virtual reality analgesia (VRA) to decrease patient procedural pain and anxiety in the Adult patients undergoing Spinal Injections (SI).

Timeline

Start
2020-11-30
Primary completion
2020-12-01
Completion
2020-12-01

Drugs

EvaluationDrugModalityDoseRoute
Background Bupivacaine Other / unclassified — —
Background Lidocaine Other / unclassified — —

Indications

No indication recorded.